Endocrinology

Top Story

Takeda: Study revealed no increased bladder cancer risk with Actos

August 2, 2015

Results of the Pan European Multi-Database Bladder Cancer Risk Characterization Study, a multi-database retrospective matched cohort study for pioglitazone containing medications, including Actos, with up to 10 years follow-up have recently been released, according to a press release from Takeda Pharmaceutical Company Limited.

“Actos is an important treatment option for patients with type 2 diabetes,” Alfonzo Perez, MD, vice president of clinical research at Takeda, said in the release. “These data further reinforce the positive benefit/risk profile for Actos. These long-term studies underscore Takeda’s commitment to ensuring physicians have the best available information to make treatment decisions.”

Treat and Reduce Obesity Act gaining momentum

August 1, 2015
More than 100 members in the House of Representatives and 10 members of the Senate are supporting the Treat and Reduce Obesity Act, according to a press release from the…
In the Journals

Top 5 online endocrine stories from July

July 31, 2015
Endocrine Today put together a compilation of the five news stories most viewed from July 2015 to keep you abreast of the current hot topics in endocrinology. …
In the Journals

Diabetes onset later in life increases dementia risk

July 31, 2015
The risk for dementia among older adults was increased with newly diagnosed diabetes, according to recent study findings published in Diabetes Care. “This is of…
Saila Koivusalo In the Journals

Moderate lifestyle intervention reduces gestational diabetes risk

July 31, 2015
Pregnant women at high risk for developing gestational diabetes can reduce their chances of developing the disease by as much as 39% through a series of moderate…
More News Headlines »
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
VIDEO: War on diabetes continues since founding in 1940

VIDEO: War on diabetes continues since founding in 1940

June 12, 2015
BOSTON — Samuel Dagogo-Jack, MD, discusses the war on diabetes declared in 1940 after an alarming 750,000…
More »
CME
Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues